ENXTPA:SANPharmaceuticals
Sanofi (ENXTPA:SAN), Why Is This Fresh Development Drawing Attention?
Sanofi (ENXTPA:SAN) is in focus after the European Commission approved an expanded indication for its MenQuadfi meningococcal vaccine, now covering infants from six weeks of age across the European Union.
See our latest analysis for Sanofi.
Sanofi’s expanded MenQuadfi approval has come as the share price trades at €76.66, with a 1-day share price return of 1.51% and year-to-date share price return down 6.88%. The 5-year total shareholder return of 6.04% indicates relatively modest longer term...